An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells

Hepatology

Volumn 51, Issue 1, 2010, Pages 351-352

  Moriguchi, Hisashi ^a,b,c   Chung, Raymond T ^b   Sato, Chifumi ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; FLUINDOSTATIN; LACTATE DEHYDROGENASE; PITAVASTATIN; RETINOID; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; COMBINATION CHEMOTHERAPY; HEPATITIS C VIRUS; HUMAN; IC 50; LETTER; LIVER CELL; MONOTHERAPY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REPLICON;

HEPATITIS C; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDUCED PLURIPOTENT STEM CELLS; INTERFERON-ALPHA; QUINOLINES; REPLICON; TRETINOIN; VIRUS REPLICATION;

EID: 73449131870     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23423     Document Type: Letter

References (5)

1. Emanuele E. Statins and hepatitis C virus: friend or foe? HEPATOLOGY 2009; doi:10.1002/hep.23087.
2. Kim SS, Peng LF, Lin W, Choe WH, Sakamoto N, Kato N, et al. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication. Gastroenterology 2007;132:311-320.
3. Naka K, Ikeda M, Abe K, Dansako H, Kato N. Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha. Biochem Biophys Res Commun 2005;330:871-879.
4. Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N. Different anti-HCV profiles of statins and their potential for combination therapy with interferon. HEPATOLOGY 2006;44:117-125.
5. Moriguchi H, Chung RT, Sato C. An identification of novel therapy for human hepatocellular carcinoma by using human induced pluripotent stem cells. HEPATOLOGY 2009; doi:10.1002/hep.23418.